www.fiercepharma.com
Open in
urlscan Pro
104.18.15.141
Public Scan
Submitted URL: https://qtx.omeclk.com/portal/wts/ucmcmQ6e%7Cx2bbc0BcD3AecnF3so0a;j2Mv-%5E83m4a
Effective URL: https://www.fiercepharma.com/?utm_medium=email&utm_source=nl&utm_campaign=LS-NL-FiercePharma+Tracker&oly_enc_id=2814C4480378J0W
Submission: On June 07 via manual from IN — Scanned from DE
Effective URL: https://www.fiercepharma.com/?utm_medium=email&utm_source=nl&utm_campaign=LS-NL-FiercePharma+Tracker&oly_enc_id=2814C4480378J0W
Submission: On June 07 via manual from IN — Scanned from DE
Form analysis
2 forms found in the DOMGET /search-results
<form action="/search-results" method="get">
<fieldset class="d-flex align-items-center position-relative input-search"><input type="text" placeholder="Search" name="fulltext_search" class="search-text w-100"><button class="search-submit d-flex align-items-center" id="search-submit"
type="submit"><svg aria-hidden="true" focusable="false" data-prefix="far" data-icon="search" class="svg-inline--fa fa-search fa-w-16" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512">
<path fill="currentColor"
d="M508.5 468.9L387.1 347.5c-2.3-2.3-5.3-3.5-8.5-3.5h-13.2c31.5-36.5 50.6-84 50.6-136C416 93.1 322.9 0 208 0S0 93.1 0 208s93.1 208 208 208c52 0 99.5-19.1 136-50.6v13.2c0 3.2 1.3 6.2 3.5 8.5l121.4 121.4c4.7 4.7 12.3 4.7 17 0l22.6-22.6c4.7-4.7 4.7-12.3 0-17zM208 368c-88.4 0-160-71.6-160-160S119.6 48 208 48s160 71.6 160 160-71.6 160-160 160z">
</path>
</svg></button><input type="hidden" placeholder="Search" name="dns" value="fiercehealthcare_com,fiercebiotech_com,fiercepharma_com"></fieldset>
</form>
GET /search-results
<form class="w-100" action="/search-results" method="get">
<fieldset class="d-flex justify-content-between position-relative input-search"><input type="text" placeholder="Search" name="fulltext_search" class="search-text w-100"><button class="search-submit d-flex align-items-center" id="search-submit"
type="submit"><svg aria-hidden="true" focusable="false" data-prefix="far" data-icon="search" class="svg-inline--fa fa-search fa-w-16" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512">
<path fill="currentColor"
d="M508.5 468.9L387.1 347.5c-2.3-2.3-5.3-3.5-8.5-3.5h-13.2c31.5-36.5 50.6-84 50.6-136C416 93.1 322.9 0 208 0S0 93.1 0 208s93.1 208 208 208c52 0 99.5-19.1 136-50.6v13.2c0 3.2 1.3 6.2 3.5 8.5l121.4 121.4c4.7 4.7 12.3 4.7 17 0l22.6-22.6c4.7-4.7 4.7-12.3 0-17zM208 368c-88.4 0-160-71.6-160-160S119.6 48 208 48s160 71.6 160 160-71.6 160-160 160z">
</path>
</svg></button></fieldset>
</form>
Text Content
* Fierce Pharma * Fierce Biotech * Fierce Healthcare * Fierce Life Sciences Events * Advertise * About Us * Manufacturing * Facilities * Recalls * Warning Letters * Marketing * Pharma * Asia * Drug Delivery * Executives * Clinical Data * Vaccines * Special Reports * Trending * COVID-19 * Cell & Gene Therapy * Podcasts * Resources * Fierce Events * Industry Events * Webinars * Podcasts * Whitepapers * Subscribe Subscribe * Manufacturing * Facilities * Recalls * Warning Letters * Marketing * Pharma * Asia * Drug Delivery * Executives * Clinical Data * Vaccines * Special Reports * Trending * COVID-19 * Cell & Gene Therapy * Podcasts * Resources * Fierce Events * Industry Events * Webinars * Podcasts * Whitepapers * Subscribe * Fierce Pharma * Fierce Biotech * Fierce Healthcare * Fierce Life Sciences Events * Advertise * About Us Pharma PARATEK BOUGHT BY NOVO HOLDINGS, GURNET POINT FOR $462M Paratek's key selling point is its antibiotic, Nuzyra, which was expected to garner $500 million in peak sales at the time of its 2018 approval. Zoey BeckerJun 6, 2023 4:21pm ARBITRATION WIN OVER J&J GIVES ALKERMES A $425M BOOST Jun 6, 2023 3:23pm Sponsored HOW TO HARMONIZE & INTERPRET SENSOR DATA IN CLINICAL TRIALS Jun 5, 2023 8:00am SANOFI, AZ GEAR UP FOR FDA ADCOMM ON RSV PROSPECT Jun 6, 2023 2:10pm EISAI HIT WITH RANSOMWARE ATTACK, LAUNCHES INVESTIGATION Jun 6, 2023 11:12am MERCK CHALLENGES HHS ON MEDICARE DRUG PRICE NEGOTIATIONS Jun 6, 2023 10:18am Manufacturing News FDA TO ALLOW TEMPORARY OVERSEAS PRODUCTION OF CHEMO DRUGS Jun 6, 2023 9:50am FOSUN PHARMA TO BUILD AFRICAN MANUFACTURING PLANT WITH IFC HELP Jun 6, 2023 9:25am INDIA'S INTAS GETS MORE BAD NEWS FROM FDA WITH IMPORT ALERT Jun 5, 2023 10:40am WUXI BIOLOGICS TO EXPAND MANUFACTURING OPERATIONS IN GERMANY Jun 2, 2023 8:05am See More Manufacturing News trending topic PHARMA ASCO: J&J's Balversa wins out over chemo in bladder cancer study Jun 5, 2023 06:39pm 'The Top Line': Democratizing access to meds, plus the headlines Jun 2, 2023 09:00am ASCO: Seagen's top-selling drug under threat from Opdivo Jun 4, 2023 12:00pm Amgen extends retraining order in Horizon pursuit Jun 5, 2023 02:56pm Pharma ASCO: Keytruda posts trial win in 'messy' early NSCLC realm Keytruda's positive readout as a perioperative regimen could further complicate what experts described as a "messy" situation in early NSCLC. Angus LiuJun 3, 2023 01:00pm See more stories Our Newsletter See more articles * Connect * The Team * Advertise * Join Us * Newsletters * Resources * RSS Feeds * Our Brands * Fierce Biotech * Fierce Healthcare * Fierce Pharma * Our Events * Life Sciences Events ©2023 Questex LLC All rights reserved. Terms of use Privacy Policy Close In order to deliver a personalized and enhanced site navigation, we store information on how you use the site. By continuing to use this site and access it's features, you are consenting to our use of cookies. For more information, please see the Questex Privacy Policy.